RL
Ruffer LLP’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.9M | Sell |
1,399,513
-792,785
| -36% | -$19.2M | 1.5% | 16 |
|
2025
Q1 | $55.6M | Sell |
2,192,298
-2,014,089
| -48% | -$51M | 2.14% | 10 |
|
2024
Q4 | $112M | Sell |
4,206,387
-2,319,901
| -36% | -$61.5M | 4.03% | 8 |
|
2024
Q3 | $189M | Buy |
6,526,288
+797,593
| +14% | +$23.1M | 5.95% | 6 |
|
2024
Q2 | $160M | Sell |
5,728,695
-178,963
| -3% | -$5.01M | 6.88% | 5 |
|
2024
Q1 | $164M | Buy |
5,907,658
+111,646
| +2% | +$3.1M | 6.31% | 4 |
|
2023
Q4 | $167M | Buy |
5,796,012
+4,133,786
| +249% | +$119M | 6.2% | 5 |
|
2023
Q3 | $53.3M | Buy |
1,662,226
+489,177
| +42% | +$15.7M | 2.95% | 12 |
|
2023
Q2 | $43M | Buy |
1,173,049
+101,370
| +9% | +$3.72M | 2.52% | 14 |
|
2023
Q1 | $43.7M | Buy |
1,071,679
+508,764
| +90% | +$20.7M | 1.51% | 24 |
|
2022
Q4 | $28.9M | Buy |
562,915
+8,140
| +1% | +$419K | 1.94% | 19 |
|
2022
Q3 | $23.9M | Buy |
554,775
+10,090
| +2% | +$435K | 1.5% | 22 |
|
2022
Q2 | $28.6M | Sell |
544,685
-33,949
| -6% | -$1.78M | 1.13% | 26 |
|
2022
Q1 | $30M | Buy |
578,634
+19,280
| +3% | +$998K | 0.7% | 33 |
|
2021
Q4 | $31.8M | Buy |
559,354
+124,464
| +29% | +$7.07M | 0.77% | 35 |
|
2021
Q3 | $18.6M | Buy |
434,890
+227,047
| +109% | +$9.7M | 0.59% | 30 |
|
2021
Q2 | $8.14M | Buy |
+207,843
| New | +$8.14M | 0.23% | 36 |
|
2015
Q2 | – | Sell |
-5,994
| Closed | -$209K | – | 101 |
|
2015
Q1 | $209K | Buy |
+5,994
| New | +$209K | 0.01% | 89 |
|
2014
Q3 | – | Sell |
-7,100
| Closed | -$213K | – | 89 |
|
2014
Q2 | $213K | Hold |
7,100
| – | – | 0.01% | 85 |
|
2014
Q1 | $228K | Hold |
7,100
| – | – | 0.01% | 89 |
|
2013
Q4 | $217K | Hold |
7,100
| – | – | 0.01% | 85 |
|
2013
Q3 | $206K | Buy |
+7,100
| New | +$206K | 0.01% | 84 |
|